Abstract |
Despite intensive chemotherapy and surgery treatment, lung and bone metastasis develop in about 30% of patients with osteosarcoma. Mechanisms for this preferential metastatic behavior are largely unknown. We investigated the role of the chemokine receptor 4 (CXCR4)/ stromal cell-derived factor 1 (SDF-1) system to drive the homing of osteosarcoma cells. We analyzed the expression of the CXCR4 and SDF-1 proteins on several osteosarcoma cell lines and the effects of SDF-1 on migration, adhesion, and proliferation of these cancer cells. In vitro assays showed that the migration of osteosarcoma cells expressing CXCR4 receptor follows an SDF-1 gradient and that their adhesion to endothelial and bone marrow stromal cells is promoted by SDF-1 treatment. Moreover, the production of matrix metalloproteinase-9 is increased after SDF-1 exposure. We finally proved in a mouse model our hypothesis of the CXCR4/SDF-1 axis involvement in the metastatic process of osteosarcoma cells. Development of lung metastasis after injection of osteosarcoma cells was prevented by the administration of a CXCR4 inhibitor, the T134 peptide. These data show a possible explanation for the preferential osteosarcoma metastatic development into the lung, where SDF-1 concentration is high, and suggest that molecular strategies aimed at inhibiting the CXCR4/SDF-1 pathway, such as small-molecule inhibitors or anti-CXCR4 antibodies, might prevent the dissemination of osteosarcoma cells.
|
Authors | Eliana Perissinotto, Giuliana Cavalloni, Francesco Leone, Valentina Fonsato, Stefania Mitola, Giovanni Grignani, Nadia Surrenti, Dario Sangiolo, Federico Bussolino, Wanda Piacibello, Massimo Aglietta |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 11
Issue 2 Pt 1
Pg. 490-7
(Jan 15 2005)
ISSN: 1078-0432 [Print] United States |
PMID | 15701832
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CXCL12 protein, human
- Chemokine CXCL12
- Chemokines, CXC
- Cxcl12 protein, mouse
- Peptide Fragments
- Receptors, CXCR4
- Matrix Metalloproteinase 9
|
Topics |
- Animals
- Bone Marrow Cells
(metabolism, pathology)
- Bone Neoplasms
(metabolism, pathology)
- Cell Adhesion
- Cell Movement
- Cell Proliferation
- Chemokine CXCL12
- Chemokines, CXC
(metabolism)
- Disease Progression
- Endothelial Cells
(metabolism, pathology)
- Female
- Humans
- Lung Neoplasms
(metabolism, prevention & control, secondary)
- Matrix Metalloproteinase 9
(metabolism)
- Mice
- Mice, Inbred BALB C
- Osteosarcoma
(metabolism, pathology)
- Peptide Fragments
(pharmacology)
- Receptors, CXCR4
(antagonists & inhibitors, metabolism)
- Signal Transduction
- Stromal Cells
(metabolism, pathology)
- Tumor Cells, Cultured
|